{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:52:54Z","timestamp":1793976774210,"version":"4.8.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Classification of head and neck tumors has evolved in recent decades including a widespread application of molecular testing in tumors of the salivary glands, sinonasal tract, oropharynx, nasopharynx, and soft tissue. Availability of new molecular techniques allowed for the definition of multiple novel tumor types unique to head and neck sites. Moreover, the expanding spectrum of immunohistochemical markers facilitates a rapid identification of diagnostic molecular abnormalities. As such, it is currently possible for head and neck pathologists to benefit from a molecularly defined classifications, while making diagnoses that are still based largely on histopathology and immunohistochemistry. This review highlights some principal molecular alterations in head and neck neoplasms presently available to assist pathologists in the practice of diagnosis, prognostication and prediction of response to treatment.<\/jats:p>","DOI":"10.1007\/s00428-023-03731-2","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T06:02:00Z","timestamp":1705125720000},"page":"215-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Molecular pathology in diagnosis and prognostication of head and neck tumors"],"prefix":"10.1007","volume":"484","author":[{"given":"Alena","family":"Sk\u00e1lov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bradov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Michael","family":"Michal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Mosaieby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lie","family":"Klub\u00ed\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Van\u011b\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilmo","family":"Leivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,13]]},"reference":[{"key":"3731_CR1","unstructured":"WHO Classification of Tumours Editorial Board (2023) Head and neck tumours. Lyon (France): International Agency for Research on Cancer; forthcoming. (WHO classification of tumours series, 5th edn, vol. 9). https:\/\/publications.iarc.fr"},{"key":"3731_CR2","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","volume":"34","author":"A Skalova","year":"2010","unstructured":"Skalova A, Vanecek T, Sima R et al (2010) Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol 34:599\u2013608. https:\/\/doi.org\/10.1097\/PAS.0b013e3181d9efcc","journal-title":"Am J Surg Pathol"},{"key":"3731_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/PAS.0000000000000972","volume":"42","author":"A Skalova","year":"2018","unstructured":"Skalova A, Vanecek T, Martinek P et al (2018) Molecular Profiling of Mammary Analog Secretory Carcinoma Revealed a Subset of Tumors Harboring a Novel ETV6-RET Translocation: Report of 10 Cases. Am J Surg Pathol 42:234\u2013246. https:\/\/doi.org\/10.1097\/PAS.0000000000000972","journal-title":"Am J Surg Pathol"},{"key":"3731_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/PAS.0000000000000088","volume":"38","author":"A Skalova","year":"2014","unstructured":"Skalova A, Vanecek T, Majewska H et al (2014) Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, beta-catenin, EGFR, and CCND1 genes. Am J Surg Pathol 38:23\u201333. https:\/\/doi.org\/10.1097\/PAS.0000000000000088","journal-title":"Am J Surg Pathol"},{"key":"3731_CR5","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/his.13281","volume":"71","author":"K Fujii","year":"2017","unstructured":"Fujii K, Murase T, Beppu S et al (2017) MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma. Histopathology 71:823\u2013834. https:\/\/doi.org\/10.1111\/his.13281","journal-title":"Histopathology"},{"key":"3731_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/modpathol.2012.154","volume":"26","author":"KJ Jee","year":"2013","unstructured":"Jee KJ, Persson M, Heikinheimo K et al (2013) Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma. Mod Pathol 26:213\u2013222. https:\/\/doi.org\/10.1038\/modpathol.2012.154","journal-title":"Mod Pathol"},{"key":"3731_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1365-2559.2011.03890.x","volume":"59","author":"Y Okumura","year":"2011","unstructured":"Okumura Y, Miyabe S, Nakayama T et al (2011) Impact of CRTC1\/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma. Histopathology 59:90\u201397. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.03890.x","journal-title":"Histopathology"},{"key":"3731_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/gcc.20881","volume":"50","author":"CR Antonescu","year":"2011","unstructured":"Antonescu CR, Katabi N, Zhang L et al (2011) EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer 50:559\u2013570. https:\/\/doi.org\/10.1002\/gcc.20881","journal-title":"Genes Chromosomes Cancer"},{"key":"3731_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/PAS.0000000000001065","volume":"42","author":"LM Rooper","year":"2018","unstructured":"Rooper LM, Karantanos T, Ning Y et al (2018) Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity. Am J Surg Pathol 42:1121\u20131126. https:\/\/doi.org\/10.1097\/PAS.0000000000001065","journal-title":"Am J Surg Pathol"},{"key":"3731_CR10","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1097\/PAS.0000000000001535","volume":"44","author":"A Skalova","year":"2020","unstructured":"Skalova A, Baneckova M, Thompson LDR et al (2020) Expanding the Molecular Spectrum of Secretory Carcinoma of Salivary Glands With a Novel VIM-RET Fusion. Am J Surg Pathol 44:1295\u20131307. https:\/\/doi.org\/10.1097\/PAS.0000000000001535","journal-title":"Am J Surg Pathol"},{"key":"3731_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1097\/PAS.0000000000001471","volume":"44","author":"E Sasaki","year":"2020","unstructured":"Sasaki E, Masago K, Fujita S et al (2020) Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6. Gene Am J Surg Pathol 44:962\u2013969. https:\/\/doi.org\/10.1097\/PAS.0000000000001471","journal-title":"Gene Am J Surg Pathol"},{"key":"3731_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.humpath.2018.08.011","volume":"83","author":"J Guilmette","year":"2019","unstructured":"Guilmette J, Dias-Santagata D, Nose V et al (2019) Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family. Hum Pathol 83:50\u201358. https:\/\/doi.org\/10.1016\/j.humpath.2018.08.011","journal-title":"Hum Pathol"},{"key":"3731_CR13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","volume":"15","author":"E Cocco","year":"2018","unstructured":"Cocco E, Scaltriti M, Drilon A (2018) NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol 15:731\u2013747. https:\/\/doi.org\/10.1038\/s41571-018-0113-0","journal-title":"Nat Rev Clin Oncol"},{"key":"3731_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2019-000612","volume":"4","author":"U Lassen","year":"2019","unstructured":"Lassen U (2019) How I treat NTRK gene fusion-positive cancers. ESMO Open 4:e000612. https:\/\/doi.org\/10.1136\/esmoopen-2019-000612","journal-title":"ESMO Open"},{"key":"3731_CR15","doi-asserted-by":"publisher","first-page":"viii23","DOI":"10.1093\/annonc\/mdz282","volume":"30","author":"A Drilon","year":"2019","unstructured":"Drilon A (2019) TRK inhibitors in TRK fusion-positive cancers. Ann Oncol 30:viii23\u2013viii30. https:\/\/doi.org\/10.1093\/annonc\/mdz282","journal-title":"Ann Oncol"},{"key":"3731_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrclinonc.2017.175","volume":"15","author":"A Drilon","year":"2018","unstructured":"Drilon A, Hu ZI, Lai GGY et al (2018) Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes. Nat Rev Clin Oncol 15:151\u2013167. https:\/\/doi.org\/10.1038\/nrclinonc.2017.175","journal-title":"Nat Rev Clin Oncol"},{"key":"3731_CR17","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1097\/PAS.0b013e3181de3021","volume":"34","author":"RR Seethala","year":"2010","unstructured":"Seethala RR, Dacic S, Cieply K et al (2010) A reappraisal of the MECT1\/MAML2 translocation in salivary mucoepidermoid carcinomas. Am J Surg Pathol 34:1106\u20131121. https:\/\/doi.org\/10.1097\/PAS.0b013e3181de3021","journal-title":"Am J Surg Pathol"},{"key":"3731_CR18","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/modpathol.2009.126","volume":"22","author":"T Nakayama","year":"2009","unstructured":"Nakayama T, Miyabe S, Okabe M et al (2009) Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma. Mod Pathol 22:1575\u20131581. https:\/\/doi.org\/10.1038\/modpathol.2009.126","journal-title":"Mod Pathol"},{"key":"3731_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/path.2327","volume":"215","author":"E Moller","year":"2008","unstructured":"Moller E, Stenman G, Mandahl N et al (2008) POU5F1, encoding a key regulator of stem cell pluripotency, is fused to EWSR1 in hidradenoma of the skin and mucoepidermoid carcinoma of the salivary glands. J Pathol 215:78\u201386. https:\/\/doi.org\/10.1002\/path.2327","journal-title":"J Pathol"},{"key":"3731_CR20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/15513815.2023.2241903","volume":"42","author":"BK Othman","year":"2023","unstructured":"Othman BK, Steiner P, Leivo I et al (2023) Rearrangement of KMT2A Characterizes a Subset of Pediatric Parotid Mucoepidermoid Carcinomas Arising Metachronous to Acute Lymphoblastic Leukemia. Fetal Pediatr Pathol 42:796\u2013807. https:\/\/doi.org\/10.1080\/15513815.2023.2241903","journal-title":"Fetal Pediatr Pathol"},{"key":"3731_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41375-022-01746-3","volume":"37","author":"LC Cheung","year":"2023","unstructured":"Cheung LC, Aya-Bonilla C, Cruickshank MN et al (2023) Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy. Leukemia 37:61\u201371. https:\/\/doi.org\/10.1038\/s41375-022-01746-3","journal-title":"Leukemia"},{"key":"3731_CR22","doi-asserted-by":"publisher","first-page":"18740","DOI":"10.1073\/pnas.0909114106","volume":"106","author":"M Persson","year":"2009","unstructured":"Persson M, Andren Y, Mark J et al (2009) Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A 106:18740\u201318744. https:\/\/doi.org\/10.1073\/pnas.0909114106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3731_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/gcc.21965","volume":"51","author":"M Persson","year":"2012","unstructured":"Persson M, Andren Y, Moskaluk CA et al (2012) Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma. Genes Chromosomes Cancer 51:805\u2013817. https:\/\/doi.org\/10.1002\/gcc.21965","journal-title":"Genes Chromosomes Cancer"},{"key":"3731_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00428-018-2349-6","volume":"473","author":"P Steiner","year":"2018","unstructured":"Steiner P, Andreasen S, Grossmann P et al (2018) Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands. Virchows Arch 473:471\u2013480. https:\/\/doi.org\/10.1007\/s00428-018-2349-6","journal-title":"Virchows Arch"},{"key":"3731_CR25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/ng.2643","volume":"45","author":"AS Ho","year":"2013","unstructured":"Ho AS, Kannan K, Roy DM et al (2013) The mutational landscape of adenoid cystic carcinoma. Nat Genet 45:791\u2013798. https:\/\/doi.org\/10.1038\/ng.2643","journal-title":"Nat Genet"},{"key":"3731_CR26","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1172\/JCI128227","volume":"129","author":"AS Ho","year":"2019","unstructured":"Ho AS, Ochoa A, Jayakumaran G et al (2019) Genetic hallmarks of recurrent\/metastatic adenoid cystic carcinoma. J Clin Invest 129:4276\u20134289. https:\/\/doi.org\/10.1172\/JCI128227","journal-title":"J Clin Invest"},{"key":"3731_CR27","doi-asserted-by":"publisher","unstructured":"Miller LE, Au V, Mokhtari TE, et al. (2022) A Contemporary Review of Molecular Therapeutic Targets for Adenoid Cystic Carcinoma. Cancers (Basel) 14.\u00a0https:\/\/doi.org\/10.3390\/cancers14040992","DOI":"10.3390\/cancers14040992"},{"key":"3731_CR28","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1158\/1078-0432.CCR-16-0637","volume":"22","author":"MG Dalin","year":"2016","unstructured":"Dalin MG, Desrichard A, Katabi N et al (2016) Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer. Clin Cancer Res 22:4623\u20134633. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0637","journal-title":"Clin Cancer Res"},{"key":"3731_CR29","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/his.12152","volume":"63","author":"A Bahrami","year":"2013","unstructured":"Bahrami A, Perez-Ordonez B, Dalton JD et al (2013) An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions. Histopathology 63:250\u2013262. https:\/\/doi.org\/10.1111\/his.12152","journal-title":"Histopathology"},{"key":"3731_CR30","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/cncr.30179","volume":"122","author":"SI Chiosea","year":"2016","unstructured":"Chiosea SI, Thompson LD, Weinreb I et al (2016) Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. Cancer 122:3136\u20133144. https:\/\/doi.org\/10.1002\/cncr.30179","journal-title":"Cancer"},{"key":"3731_CR31","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1097\/PAS.0000000000001698","volume":"45","author":"A Agaimy","year":"2021","unstructured":"Agaimy A, Baneckova M, Ihrler S et al (2021) ALK Rearrangements Characterize 2 Distinct Types of Salivary Gland Carcinomas: Clinicopathologic and Molecular Analysis of 4 Cases and Literature Review. Am J Surg Pathol 45:1166\u20131178. https:\/\/doi.org\/10.1097\/PAS.0000000000001698","journal-title":"Am J Surg Pathol"},{"key":"3731_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.humpath.2019.08.009","volume":"93","author":"T Santana","year":"2019","unstructured":"Santana T, Pavel A, Martinek P et al (2019) Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications. Hum Pathol 93:37\u201347. https:\/\/doi.org\/10.1016\/j.humpath.2019.08.009","journal-title":"Hum Pathol"},{"key":"3731_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102069","volume":"89","author":"MJM Uijen","year":"2020","unstructured":"Uijen MJM, Lassche G, van Engen-van Grunsven ACH et al (2020) Systemic therapy in the management of recurrent or metastatic salivary duct carcinoma: A systematic review. Cancer Treat Rev 89:102069. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102069","journal-title":"Cancer Treat Rev"},{"key":"3731_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.path.2020.09.010","volume":"14","author":"M Rahman","year":"2021","unstructured":"Rahman M, Griffith CC (2021) Salivary Duct Carcinoma: An Aggressive Salivary Gland Carcinoma with Morphologic Variants Newly Identified Molecular Characteristics, and Emerging Treatment Modalities. Surg Pathol Clin 14:111\u2013126. https:\/\/doi.org\/10.1016\/j.path.2020.09.010","journal-title":"Surg Pathol Clin"},{"key":"3731_CR35","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1097\/PAS.0000000000001114","volume":"42","author":"E Chapman","year":"2018","unstructured":"Chapman E, Skalova A, Ptakova N et al (2018) Molecular Profiling of Hyalinizing Clear Cell Carcinomas Revealed a Subset of Tumors Harboring a Novel EWSR1-CREM Fusion: Report of 3 Cases. Am J Surg Pathol 42:1182\u20131189. https:\/\/doi.org\/10.1097\/PAS.0000000000001114","journal-title":"Am J Surg Pathol"},{"key":"3731_CR36","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1097\/PAS.0000000000000980","volume":"42","author":"A Skalova","year":"2018","unstructured":"Skalova A, Stenman G, Simpson RHW et al (2018) The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas. Am J Surg Pathol 42:e11\u2013e27. https:\/\/doi.org\/10.1097\/PAS.0000000000000980","journal-title":"Am J Surg Pathol"},{"key":"3731_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.path.2020.10.002","volume":"14","author":"M Nakaguro","year":"2021","unstructured":"Nakaguro M, Nagao T (2021) Epithelial-Myoepithelial Carcinoma. Surg Pathol Clin 14:97\u2013109. https:\/\/doi.org\/10.1016\/j.path.2020.10.002","journal-title":"Surg Pathol Clin"},{"key":"3731_CR38","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/PAS.0000000000001258","volume":"43","author":"M Urano","year":"2019","unstructured":"Urano M, Nakaguro M, Yamamoto Y et al (2019) Diagnostic Significance of HRAS Mutations in Epithelial-Myoepithelial Carcinomas Exhibiting a Broad Histopathologic Spectrum. Am J Surg Pathol 43:984\u2013994. https:\/\/doi.org\/10.1097\/PAS.0000000000001258","journal-title":"Am J Surg Pathol"},{"key":"3731_CR39","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1046\/j.1365-2559.1999.00792.x","volume":"35","author":"M Michal","year":"1999","unstructured":"Michal M, Skalova A, Simpson RH et al (1999) Cribriform adenocarcinoma of the tongue: a hitherto unrecognized type of adenocarcinoma characteristically occurring in the tongue. Histopathology 35:495\u2013501. https:\/\/doi.org\/10.1046\/j.1365-2559.1999.00792.x","journal-title":"Histopathology"},{"key":"3731_CR40","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/PAS.0b013e31821e1f54","volume":"35","author":"A Skalova","year":"2011","unstructured":"Skalova A, Sima R, Kaspirkova-Nemcova J et al (2011) Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of new entity. Am J Surg Pathol 35:1168\u20131176. https:\/\/doi.org\/10.1097\/PAS.0b013e31821e1f54","journal-title":"Am J Surg Pathol"},{"key":"3731_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41379-019-0351-4","volume":"33","author":"APM Sebastiao","year":"2020","unstructured":"Sebastiao APM, Xu B, Lozada JR et al (2020) Histologic spectrum of polymorphous adenocarcinoma of the salivary gland harbor genetic alterations affecting PRKD genes. Mod Pathol 33:65\u201373. https:\/\/doi.org\/10.1038\/s41379-019-0351-4","journal-title":"Mod Pathol"},{"key":"3731_CR42","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/gcc.23181","volume":"62","author":"AA Owosho","year":"2023","unstructured":"Owosho AA, Baker E, Wood CB et al (2023) A novel STRN3::PRKD1 fusion in a cribriform adenocarcinoma of salivary gland with high-grade transformation. Genes Chromosomes Cancer 62:624\u2013628. https:\/\/doi.org\/10.1002\/gcc.23181","journal-title":"Genes Chromosomes Cancer"},{"key":"3731_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100305","volume":"36","author":"E Hahn","year":"2023","unstructured":"Hahn E, Xu B, Katabi N et al (2023) Comprehensive Molecular Characterization of Polymorphous Adenocarcinoma, Cribriform Subtype: Identifying Novel Fusions and Fusion Partners. Mod Pathol 36:100305. https:\/\/doi.org\/10.1016\/j.modpat.2023.100305","journal-title":"Mod Pathol"},{"key":"3731_CR44","doi-asserted-by":"publisher","unstructured":"Stenman G, Fehr A, Skalova A, et al. (2022) Chromosome Translocations, Gene Fusions, and Their Molecular Consequences in Pleomorphic Salivary Gland Adenomas. Biomedicines 10. doi: https:\/\/doi.org\/10.3390\/biomedicines10081970","DOI":"10.3390\/biomedicines10081970"},{"issue":"Suppl 1","key":"3731_CR45","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1007\/s12105-013-0462-z","volume":"7","author":"G Stenman","year":"2013","unstructured":"Stenman G (2013) Fusion oncogenes in salivary gland tumors: molecular and clinical consequences. Head Neck Pathol 7(Suppl 1):S12-19. https:\/\/doi.org\/10.1007\/s12105-013-0462-z","journal-title":"Head Neck Pathol"},{"key":"3731_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/his.13341","volume":"72","author":"N Katabi","year":"2018","unstructured":"Katabi N, Xu B, Jungbluth AA et al (2018) PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities. Histopathology 72:285\u2013293. https:\/\/doi.org\/10.1111\/his.13341","journal-title":"Histopathology"},{"key":"3731_CR47","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/his.13246","volume":"71","author":"JK Mito","year":"2017","unstructured":"Mito JK, Jo VY, Chiosea SI et al (2017) HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma. Histopathology 71:511\u2013521. https:\/\/doi.org\/10.1111\/his.13246","journal-title":"Histopathology"},{"key":"3731_CR48","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/PAS.0000000000001273","volume":"43","author":"JA Bishop","year":"2019","unstructured":"Bishop JA, Weinreb I, Swanson D et al (2019) Microsecretory Adenocarcinoma: A Novel Salivary Gland Tumor Characterized by a Recurrent MEF2C-SS18 Fusion. Am J Surg Pathol 43:1023\u20131032. https:\/\/doi.org\/10.1097\/PAS.0000000000001273","journal-title":"Am J Surg Pathol"},{"key":"3731_CR49","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41591-019-0434-2","volume":"25","author":"W Yang","year":"2019","unstructured":"Yang W, Lee KW, Srivastava RM et al (2019) Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat Med 25:767\u2013775. https:\/\/doi.org\/10.1038\/s41591-019-0434-2","journal-title":"Nat Med"},{"key":"3731_CR50","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1097\/PAS.0000000000001498","volume":"44","author":"E Todorovic","year":"2020","unstructured":"Todorovic E, Truong T, Eskander A et al (2020) Middle Ear and Temporal Bone Nonkeratinizing Squamous Cell Carcinomas With DEK-AFF2 Fusion: An Emerging Entity. Am J Surg Pathol 44:1244\u20131250. https:\/\/doi.org\/10.1097\/PAS.0000000000001498","journal-title":"Am J Surg Pathol"},{"key":"3731_CR51","first-page":"304","volume":"63","author":"CA French","year":"2003","unstructured":"French CA, Miyoshi I, Kubonishi I et al (2003) BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 63:304\u2013307","journal-title":"Cancer Res"},{"key":"3731_CR52","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1128\/MCB.23.15.5354-5365.2003","volume":"23","author":"C Pivot-Pajot","year":"2003","unstructured":"Pivot-Pajot C, Caron C, Govin J et al (2003) Acetylation-dependent chromatin reorganization by BRDT, a testis-specific bromodomain-containing protein. Mol Cell Biol 23:5354\u20135365. https:\/\/doi.org\/10.1128\/MCB.23.15.5354-5365.2003","journal-title":"Mol Cell Biol"},{"key":"3731_CR53","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1038\/sj.onc.1210852","volume":"27","author":"CA French","year":"2008","unstructured":"French CA, Ramirez CL, Kolmakova J et al (2008) BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene 27:2237\u20132242. https:\/\/doi.org\/10.1038\/sj.onc.1210852","journal-title":"Oncogene"},{"key":"3731_CR54","doi-asserted-by":"publisher","first-page":"1018439","DOI":"10.1155\/2019\/1018439","volume":"2019","author":"QW Huang","year":"2019","unstructured":"Huang QW, He LJ, Zheng S et al (2019) An Overview of Molecular Mechanism Clinicopathological Factors, and Treatment in NUT Carcinoma. Biomed Res Int 2019:1018439. https:\/\/doi.org\/10.1155\/2019\/1018439","journal-title":"Biomed Res Int"},{"key":"3731_CR55","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/PAS.0b013e318198d666","volume":"33","author":"H Haack","year":"2009","unstructured":"Haack H, Johnson LA, Fry CJ et al (2009) Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 33:984\u2013991. https:\/\/doi.org\/10.1097\/PAS.0b013e318198d666","journal-title":"Am J Surg Pathol"},{"key":"3731_CR56","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1158\/2159-8290.CD-14-0014","volume":"4","author":"CA French","year":"2014","unstructured":"French CA, Rahman S, Walsh EM et al (2014) NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov 4:928\u2013941. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0014","journal-title":"Cancer Discov"},{"key":"3731_CR57","doi-asserted-by":"publisher","first-page":"E4184","DOI":"10.1073\/pnas.1702086114","volume":"114","author":"AA Alekseyenko","year":"2017","unstructured":"Alekseyenko AA, Walsh EM, Zee BM et al (2017) Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma. Proc Natl Acad Sci U S A 114:E4184\u2013E4192. https:\/\/doi.org\/10.1073\/pnas.1702086114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3731_CR58","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1158\/1078-0432.CCR-12-1153","volume":"18","author":"DE Bauer","year":"2012","unstructured":"Bauer DE, Mitchell CM, Strait KM et al (2012) Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res 18:5773\u20135779. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1153","journal-title":"Clin Cancer Res"},{"key":"3731_CR59","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos P, Qi J, Picaud S et al (2010) Selective inhibition of BET bromodomains. Nature 468:1067\u20131073. https:\/\/doi.org\/10.1038\/nature09504","journal-title":"Nature"},{"key":"3731_CR60","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1158\/1078-0432.CCR-13-0280","volume":"20","author":"X Wang","year":"2014","unstructured":"Wang X, Haswell JR, Roberts CW (2014) Molecular pathways: SWI\/SNF (BAF) complexes are frequently mutated in cancer\u2013mechanisms and potential therapeutic insights. Clin Cancer Res 20:21\u201327. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0280","journal-title":"Clin Cancer Res"},{"key":"3731_CR61","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/PAS.0000000000000797","volume":"41","author":"A Agaimy","year":"2017","unstructured":"Agaimy A, Hartmann A, Antonescu CR et al (2017) SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity. Am J Surg Pathol 41:458\u2013471. https:\/\/doi.org\/10.1097\/PAS.0000000000000797","journal-title":"Am J Surg Pathol"},{"key":"3731_CR62","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/PAS.0000000000001428","volume":"44","author":"A Agaimy","year":"2020","unstructured":"Agaimy A, Jain D, Uddin N et al (2020) SMARCA4-deficient Sinonasal Carcinoma: A Series of 10 Cases Expanding the Genetic Spectrum of SWI\/SNF-driven Sinonasal Malignancies. Am J Surg Pathol 44:703\u2013710. https:\/\/doi.org\/10.1097\/PAS.0000000000001428","journal-title":"Am J Surg Pathol"},{"key":"3731_CR63","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/PAP.0000000000000372","volume":"30","author":"A Agaimy","year":"2023","unstructured":"Agaimy A (2023) SWI\/SNF-deficient Sinonasal Carcinomas. Adv Anat Pathol 30:95\u2013103. https:\/\/doi.org\/10.1097\/PAP.0000000000000372","journal-title":"Adv Anat Pathol"},{"key":"3731_CR64","doi-asserted-by":"publisher","unstructured":"Ngo C, Postel-Vinay S (2022) Immunotherapy for SMARCB1-Deficient sarcomas: current evidence and future developments. Biomedicines 10. doi: https:\/\/doi.org\/10.3390\/biomedicines10030650","DOI":"10.3390\/biomedicines10030650"},{"key":"3731_CR65","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/annonc\/mdy050","volume":"29","author":"S Aspeslagh","year":"2018","unstructured":"Aspeslagh S, Morel D, Soria JC et al (2018) Epigenetic modifiers as new immunomodulatory therapies in solid tumours. Ann Oncol 29:812\u2013824. https:\/\/doi.org\/10.1093\/annonc\/mdy050","journal-title":"Ann Oncol"},{"key":"3731_CR66","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/modpathol.2016.239","volume":"30","author":"VY Jo","year":"2017","unstructured":"Jo VY, Chau NG, Hornick JL et al (2017) Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma. Mod Pathol 30:650\u2013659. https:\/\/doi.org\/10.1038\/modpathol.2016.239","journal-title":"Mod Pathol"},{"key":"3731_CR67","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/path.4915","volume":"242","author":"S Dogan","year":"2017","unstructured":"Dogan S, Chute DJ, Xu B et al (2017) Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas. J Pathol 242:400\u2013408. https:\/\/doi.org\/10.1002\/path.4915","journal-title":"J Pathol"},{"key":"3731_CR68","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/PAS.0000000000001420","volume":"44","author":"C Riobello","year":"2020","unstructured":"Riobello C, Lopez-Hernandez A, Cabal VN et al (2020) IDH2 Mutation Analysis in Undifferentiated and Poorly Differentiated Sinonasal Carcinomas for Diagnosis and Clinical Management. Am J Surg Pathol 44:396\u2013405. https:\/\/doi.org\/10.1097\/PAS.0000000000001420","journal-title":"Am J Surg Pathol"},{"key":"3731_CR69","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/PAS.0000000000001064","volume":"42","author":"JK Mito","year":"2018","unstructured":"Mito JK, Bishop JA, Sadow PM et al (2018) Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas. Am J Surg Pathol 42:1067\u20131075. https:\/\/doi.org\/10.1097\/PAS.0000000000001064","journal-title":"Am J Surg Pathol"},{"key":"3731_CR70","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1055\/s-0034-1390016","volume":"76","author":"KJ Chambers","year":"2015","unstructured":"Chambers KJ, Lehmann AE, Remenschneider A et al (2015) Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States J Neurol Surg B. Skull Base 76:94\u2013100. https:\/\/doi.org\/10.1055\/s-0034-1390016","journal-title":"Skull Base"},{"key":"3731_CR71","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/PAS.0b013e31827b1cd6","volume":"37","author":"JA Bishop","year":"2013","unstructured":"Bishop JA, Ogawa T, Stelow EB et al (2013) Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract. Am J Surg Pathol 37:836\u2013844. https:\/\/doi.org\/10.1097\/PAS.0b013e31827b1cd6","journal-title":"Am J Surg Pathol"},{"key":"3731_CR72","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1055\/s-0039-3399571","volume":"80","author":"AI Rodarte","year":"2019","unstructured":"Rodarte AI, Parikh AS, Gadkaree SK et al (2019) Human Papillomavirus Related Multiphenotypic Sinonasal Carcinoma: Report of a Case with Early and Progressive Metastatic Disease. J Neurol Surg Rep 80:e41\u2013e43. https:\/\/doi.org\/10.1055\/s-0039-3399571","journal-title":"J Neurol Surg Rep"},{"key":"3731_CR73","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ng.2989","volume":"46","author":"X Wang","year":"2014","unstructured":"Wang X, Bledsoe KL, Graham RP et al (2014) Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nat Genet 46:666\u2013668. https:\/\/doi.org\/10.1038\/ng.2989","journal-title":"Nat Genet"},{"key":"3731_CR74","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/his.13045","volume":"69","author":"KJ Fritchie","year":"2016","unstructured":"Fritchie KJ, Jin L, Wang X et al (2016) Fusion gene profile of biphenotypic sinonasal sarcoma: an analysis of 44 cases. Histopathology 69:930\u2013936. https:\/\/doi.org\/10.1111\/his.13045","journal-title":"Histopathology"},{"key":"3731_CR75","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/PAS.0000000000001238","volume":"43","author":"F Le Loarer","year":"2019","unstructured":"Le Loarer F, Laffont S, Lesluyes T et al (2019) Clinicopathologic and Molecular Features of a Series of 41 Biphenotypic Sinonasal Sarcomas Expanding Their Molecular Spectrum. Am J Surg Pathol 43:747\u2013754. https:\/\/doi.org\/10.1097\/PAS.0000000000001238","journal-title":"Am J Surg Pathol"},{"key":"3731_CR76","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12105-022-01479-w","volume":"17","author":"MM Nichols","year":"2023","unstructured":"Nichols MM, Alruwaii F, Chaaban M et al (2023) Biphenotypic Sinonasal Sarcoma with a Novel PAX3::FOXO6 Fusion: A Case Report and Review of the Literature. Head Neck Pathol 17:259\u2013264. https:\/\/doi.org\/10.1007\/s12105-022-01479-w","journal-title":"Head Neck Pathol"},{"key":"3731_CR77","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/0145561321999196","volume":"102","author":"E Kominsky","year":"2023","unstructured":"Kominsky E, Boyke AE, Madani D et al (2023) Biphenotypic Sinonasal Sarcoma: A Case Report and Review of Literature. Ear Nose Throat J 102:385\u2013390. https:\/\/doi.org\/10.1177\/0145561321999196","journal-title":"Ear Nose Throat J"},{"key":"3731_CR78","doi-asserted-by":"publisher","first-page":"151889","DOI":"10.1016\/j.anndiagpath.2021.151889","volume":"57","author":"D Bell","year":"2022","unstructured":"Bell D, Phan J, DeMonte F et al (2022) High-grade transformation of low-grade biphenotypic sinonasal sarcoma: Radiological, morphophenotypic variation and confirmatory molecular analysis. Ann Diagn Pathol 57:151889. https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151889","journal-title":"Ann Diagn Pathol"},{"key":"3731_CR79","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1055\/s-0042-1755599","volume":"83","author":"S Hasnie","year":"2022","unstructured":"Hasnie S, Glenn C, Peterson JEG et al (2022) High-Grade Biphenotypic Sinonasal Sarcoma: A Case Report. J Neurol Surg Rep 83:e105\u2013e109. https:\/\/doi.org\/10.1055\/s-0042-1755599","journal-title":"J Neurol Surg Rep"},{"key":"3731_CR80","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00428-023-03501-0","volume":"482","author":"A Meyer","year":"2023","unstructured":"Meyer A, Klubickova N, Mosaieby E et al (2023) Biphenotypic sinonasal sarcoma with PAX3::MAML3 fusion transforming into high-grade rhabdomyosarcoma: report of an emerging rare phenomenon. Virchows Arch 482:777\u2013782. https:\/\/doi.org\/10.1007\/s00428-023-03501-0","journal-title":"Virchows Arch"},{"key":"3731_CR81","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1158\/1078-0432.CCR-17-3089","volume":"24","author":"KAP Schultz","year":"2018","unstructured":"Schultz KAP, Williams GM, Kamihara J et al (2018) DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies. Clin Cancer Res 24:2251\u20132261. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3089","journal-title":"Clin Cancer Res"},{"key":"3731_CR82","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00428-022-03389-2","volume":"481","author":"N Klubickova","year":"2022","unstructured":"Klubickova N, Michal M, Agaimy A et al (2022) TIMP3::ALK fusions characterize a distinctive myxoid fibroblastic tumor of the vocal cords: a report of 7 cases. Virchows Arch 481:721\u2013729. https:\/\/doi.org\/10.1007\/s00428-022-03389-2","journal-title":"Virchows Arch"},{"key":"3731_CR83","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1097\/PAS.0000000000001735","volume":"45","author":"DA Kerr","year":"2021","unstructured":"Kerr DA, Thompson LDR, Tafe LJ et al (2021) Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall. Am J Surg Pathol 45:1707\u20131719. https:\/\/doi.org\/10.1097\/PAS.0000000000001735","journal-title":"Am J Surg Pathol"},{"key":"3731_CR84","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00000478-199505000-00003","volume":"19","author":"BC Smith","year":"1995","unstructured":"Smith BC, Ellis GL, Meis-Kindblom JM et al (1995) Ectomesenchymal chondromyxoid tumor of the anterior tongue Nineteen cases of a new clinicopathologic entity. Am J Surg Pathol 19:519\u2013530. https:\/\/doi.org\/10.1097\/00000478-199505000-00003","journal-title":"Am J Surg Pathol"},{"key":"3731_CR85","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12105-020-01169-5","volume":"15","author":"J Bubola","year":"2021","unstructured":"Bubola J, Hagen K, Blanas N et al (2021) Expanding awareness of the distribution and biologic potential of ectomesenchymal chondromyxoid tumor. Head Neck Pathol 15:319\u2013322. https:\/\/doi.org\/10.1007\/s12105-020-01169-5","journal-title":"Head Neck Pathol"},{"key":"3731_CR86","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/his.12973","volume":"69","author":"PP Argyris","year":"2016","unstructured":"Argyris PP, Bilodeau EA, Yancoskie AE et al (2016) A subset of ectomesenchymal chondromyxoid tumours of the tongue show EWSR1 rearrangements and are genetically linked to soft tissue myoepithelial neoplasms: a study of 11 cases. Histopathology 69:607\u2013613. https:\/\/doi.org\/10.1111\/his.12973","journal-title":"Histopathology"},{"key":"3731_CR87","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1097\/PAS.0000000000001096","volume":"42","author":"BC Dickson","year":"2018","unstructured":"Dickson BC, Antonescu CR, Argyris PP et al (2018) Ectomesenchymal chondromyxoid tumor: a neoplasm characterized by recurrent RREB1-MKL2 fusions. Am J Surg Pathol 42:1297\u20131305. https:\/\/doi.org\/10.1097\/PAS.0000000000001096","journal-title":"Am J Surg Pathol"},{"key":"3731_CR88","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/gcc.23082","volume":"62","author":"A Agaimy","year":"2023","unstructured":"Agaimy A, Din NU, Dermawan JK et al (2023) RREB1::MRTFB fusion-positive extra-glossal mesenchymal neoplasms: A series of five cases expanding their anatomic distribution and highlighting significant morphological and phenotypic diversity. Genes Chromosomes Cancer 62:5\u201316. https:\/\/doi.org\/10.1002\/gcc.23082","journal-title":"Genes Chromosomes Cancer"},{"key":"3731_CR89","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/s0002-9440(10)63723-6","volume":"164","author":"A Dahlen","year":"2004","unstructured":"Dahlen A, Fletcher CD, Mertens F et al (2004) Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12). Am J Pathol 164:1645\u20131653. https:\/\/doi.org\/10.1016\/s0002-9440(10)63723-6","journal-title":"Am J Pathol"},{"key":"3731_CR90","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PAS.0000000000001979","volume":"47","author":"DJ Papke Jr","year":"2023","unstructured":"Papke DJ Jr, Dickson BC, Oliveira AM et al (2023) Distinctive nested glomoid neoplasm: clinicopathologic analysis of 20 cases of a mesenchymal neoplasm with frequent GLI1 alterations and indolent behavior. Am J Surg Pathol 47:12\u201324. https:\/\/doi.org\/10.1097\/PAS.0000000000001979","journal-title":"Am J Surg Pathol"},{"key":"3731_CR91","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/s41379-019-0293-x","volume":"32","author":"NP Agaram","year":"2019","unstructured":"Agaram NP, Zhang L, Sung YS et al (2019) GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions. Mod Pathol 32:1617\u20131626. https:\/\/doi.org\/10.1038\/s41379-019-0293-x","journal-title":"Mod Pathol"},{"key":"3731_CR92","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/PAS.0000000000002018","volume":"47","author":"PH Parrack","year":"2023","unstructured":"Parrack PH, Marino-Enriquez A, Fletcher CDM et al (2023) GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics. Am J Surg Pathol 47:453\u2013460. https:\/\/doi.org\/10.1097\/PAS.0000000000002018","journal-title":"Am J Surg Pathol"},{"key":"3731_CR93","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/PAS.0000000000001439","volume":"44","author":"B Xu","year":"2020","unstructured":"Xu B, Chang K, Folpe AL et al (2020) Head and Neck Mesenchymal Neoplasms With GLI1 Gene Alterations: A Pathologic Entity With Distinct Histologic Features and Potential for Distant Metastasis. Am J Surg Pathol 44:729\u2013737. https:\/\/doi.org\/10.1097\/PAS.0000000000001439","journal-title":"Am J Surg Pathol"},{"key":"3731_CR94","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/PAS.0000000000001010","volume":"42","author":"CR Antonescu","year":"2018","unstructured":"Antonescu CR, Agaram NP, Sung YS et al (2018) A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB\/MALAT1\/PTCH1-GLI1 Fusions. Am J Surg Pathol 42:553\u2013560. https:\/\/doi.org\/10.1097\/PAS.0000000000001010","journal-title":"Am J Surg Pathol"},{"key":"3731_CR95","unstructured":"WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon (France): International Agency for Research on Cancer; 2020. (WHO classification of tumours series, 5th ed.; vol. 3). https:\/\/publications.iarc.fr\/588."},{"key":"3731_CR96","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00428-019-02676-9","volume":"476","author":"J Leiner","year":"2020","unstructured":"Leiner J, Le Loarer F (2020) The current landscape of rhabdomyosarcomas: an update. Virchows Arch 476:97\u2013108. https:\/\/doi.org\/10.1007\/s00428-019-02676-9","journal-title":"Virchows Arch"},{"key":"3731_CR97","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/gcc.22050","volume":"52","author":"JM Mosquera","year":"2013","unstructured":"Mosquera JM, Sboner A, Zhang L et al (2013) Recurrent NCOA2 gene rearrangements in congenital\/infantile spindle cell rhabdomyosarcoma. Genes Chromosomes Cancer 52:538\u2013550. https:\/\/doi.org\/10.1002\/gcc.22050","journal-title":"Genes Chromosomes Cancer"},{"key":"3731_CR98","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/PAS.0000000000000538","volume":"40","author":"R Alaggio","year":"2016","unstructured":"Alaggio R, Zhang L, Sung YS et al (2016) A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases. Am J Surg Pathol 40:224\u2013235. https:\/\/doi.org\/10.1097\/PAS.0000000000000538","journal-title":"Am J Surg Pathol"},{"key":"3731_CR99","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/gcc.23083","volume":"61","author":"A Agaimy","year":"2022","unstructured":"Agaimy A, Dermawan JK, Leong I et al (2022) Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck. Genes Chromosomes Cancer 61:701\u2013709. https:\/\/doi.org\/10.1002\/gcc.23083","journal-title":"Genes Chromosomes Cancer"},{"key":"3731_CR100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/path.5053","volume":"245","author":"S Watson","year":"2018","unstructured":"Watson S, Perrin V, Guillemot D et al (2018) Transcriptomic definition of molecular subgroups of small round cell sarcomas. J Pathol 245:29\u201340. https:\/\/doi.org\/10.1002\/path.5053","journal-title":"J Pathol"},{"key":"3731_CR101","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41379-019-0323-8","volume":"33","author":"F Le Loarer","year":"2020","unstructured":"Le Loarer F, Cleven AHG, Bouvier C et al (2020) A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation. Mod Pathol 33:404\u2013419. https:\/\/doi.org\/10.1038\/s41379-019-0323-8","journal-title":"Mod Pathol"},{"key":"3731_CR102","doi-asserted-by":"publisher","first-page":"100271","DOI":"10.1016\/j.modpat.2023.100271","volume":"36","author":"CA Dehner","year":"2023","unstructured":"Dehner CA, Broski SM, Meis JM et al (2023) Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases. Mod Pathol 36:100271. https:\/\/doi.org\/10.1016\/j.modpat.2023.100271","journal-title":"Mod Pathol"},{"key":"3731_CR103","doi-asserted-by":"publisher","first-page":"e28185","DOI":"10.1002\/pbc.28185","volume":"67","author":"AC Brunac","year":"2020","unstructured":"Brunac AC, Laprie A, Castex MP et al (2020) The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript. Pediatr Blood Cancer 67:e28185. https:\/\/doi.org\/10.1002\/pbc.28185","journal-title":"Pediatr Blood Cancer"},{"key":"3731_CR104","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1177\/10668969221140397","volume":"31","author":"E Valerio","year":"2023","unstructured":"Valerio E, Furtado Costa JL, Perez Fraile NM et al (2023) Intraosseous Spindle Cell\/Epithelioid Rhabdomyosarcoma with TFCP2 Rearrangement: A Recent Recognized Subtype with Partial Response to Alectinib. Int J Surg Pathol 31:861\u2013865. https:\/\/doi.org\/10.1177\/10668969221140397","journal-title":"Int J Surg Pathol"},{"key":"3731_CR105","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/00000478-199902000-00004","volume":"23","author":"JA Bridge","year":"1999","unstructured":"Bridge JA, Fidler ME, Neff JR et al (1999) Adamantinoma-like Ewing\u2019s sarcoma: genomic confirmation, phenotypic drift. Am J Surg Pathol 23:159\u2013165. https:\/\/doi.org\/10.1097\/00000478-199902000-00004","journal-title":"Am J Surg Pathol"},{"key":"3731_CR106","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12105-019-01098-y","volume":"14","author":"LM Rooper","year":"2020","unstructured":"Rooper LM, Bishop JA (2020) Soft Tissue Special Issue: Adamantinoma-Like Ewing Sarcoma of the Head and Neck: A Practical Review of a Challenging Emerging Entity. Head Neck Pathol 14:59\u201369. https:\/\/doi.org\/10.1007\/s12105-019-01098-y","journal-title":"Head Neck Pathol"},{"key":"3731_CR107","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/PAS.0000000000001982","volume":"47","author":"B Xu","year":"2023","unstructured":"Xu B, Suurmeijer AJH, Agaram NP et al (2023) Head and Neck Mesenchymal Tumors with Kinase Fusions: A Report of 15 Cases With Emphasis on Wide Anatomic Distribution and Diverse Histologic Appearance. Am J Surg Pathol 47:248\u2013258. https:\/\/doi.org\/10.1097\/PAS.0000000000001982","journal-title":"Am J Surg Pathol"},{"key":"3731_CR108","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/his.14443","volume":"80","author":"JL Davis","year":"2022","unstructured":"Davis JL, Al-Ibraheemi A, Rudzinski ER et al (2022) Mesenchymal neoplasms with NTRK and other kinase gene alterations. Histopathology 80:4\u201318. https:\/\/doi.org\/10.1111\/his.14443","journal-title":"Histopathology"},{"key":"3731_CR109","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","volume":"33","author":"JP Solomon","year":"2020","unstructured":"Solomon JP, Linkov I, Rosado A et al (2020) NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Mod Pathol 33:38\u201346. https:\/\/doi.org\/10.1038\/s41379-019-0324-7","journal-title":"Mod Pathol"},{"key":"3731_CR110","doi-asserted-by":"publisher","first-page":"100337","DOI":"10.1016\/j.modpat.2023.100337","volume":"36","author":"O Koshyk","year":"2023","unstructured":"Koshyk O, Dehner CA, van den Hout M et al (2023) EWSR1::POU2AF3(COLCA2) Sarcoma: An aggressive, polyphenotypic sarcoma with a head and neck predilection. Mod Pathol 36:100337. https:\/\/doi.org\/10.1016\/j.modpat.2023.100337","journal-title":"Mod Pathol"},{"key":"3731_CR111","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/gcc.23136","volume":"62","author":"MC Hiemenz","year":"2023","unstructured":"Hiemenz MC, Kaur J, Kuang Z et al (2023) POU2AF3-rearranged sarcomas: A novel tumor defined by fusions of EWSR1 or FUS to a gene formerly designated COLCA2 Genes Chromosomes. Cancer 62:460\u2013470. https:\/\/doi.org\/10.1002\/gcc.23136","journal-title":"Cancer"},{"key":"3731_CR112","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/PAS.0000000000002000","volume":"47","author":"A Agaimy","year":"2023","unstructured":"Agaimy A, Baneckova M, De Almeida J et al (2023) Recurrent EWSR1::COLCA2 Fusions Define a Novel Sarcoma With Spindle\/Round Cell Morphology and Strong Predilection for the sinonasal tract. Am J Surg Pathol 47:361\u2013369. https:\/\/doi.org\/10.1097\/PAS.0000000000002000","journal-title":"Am J Surg Pathol"},{"key":"3731_CR113","first-page":"208","volume":"38","author":"E Muller","year":"2000","unstructured":"Muller E, Beleites E (2000) The basaloid squamous cell carcinoma of the nasopharynx. Rhinology 38:208\u2013211","journal-title":"Rhinology"},{"key":"3731_CR114","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005130","volume":"95","author":"J Zhang","year":"2016","unstructured":"Zhang J, Shu C, Song Y et al (2016) Epstein-Barr virus DNA level as a novel prognostic factor in nasopharyngeal carcinoma: A meta-analysis. Medicine (Baltimore) 95:e5130. https:\/\/doi.org\/10.1097\/MD.0000000000005130","journal-title":"Medicine (Baltimore)"},{"key":"3731_CR115","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/hed.25450","volume":"41","author":"M Ruuskanen","year":"2019","unstructured":"Ruuskanen M, Irjala H, Minn H et al (2019) Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland. Head Neck 41:349\u2013357. https:\/\/doi.org\/10.1002\/hed.25450","journal-title":"Head Neck"},{"key":"3731_CR116","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/hed.23362","volume":"36","author":"Z Lin","year":"2014","unstructured":"Lin Z, Khong B, Kwok S et al (2014) Human papillomavirus 16 detected in nasopharyngeal carcinomas in white Americans but not in endemic Southern Chinese patients. Head Neck 36:709\u2013714. https:\/\/doi.org\/10.1002\/hed.23362","journal-title":"Head Neck"},{"key":"3731_CR117","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/v13071326","volume":"13","author":"AF Carlander","year":"2021","unstructured":"Carlander AF, Jakobsen KK, Bendtsen SK et al (2021) A Contemporary Systematic Review on Repartition of HPV-Positivity in Oropharyngeal Cancer Worldwide. Viruses 13:1326. https:\/\/doi.org\/10.3390\/v13071326","journal-title":"Viruses"},{"key":"3731_CR118","doi-asserted-by":"publisher","first-page":"105109","DOI":"10.1016\/j.oraloncology.2020.105109","volume":"113","author":"SS Mashiana","year":"2021","unstructured":"Mashiana SS, Navale P, Khandakar B et al (2021) Human papillomavirus genotype distribution in head and neck cancer: Informing developing strategies for cancer prevention, diagnosis, treatment and surveillance. Oral Oncol 113:105109. https:\/\/doi.org\/10.1016\/j.oraloncology.2020.105109","journal-title":"Oral Oncol"},{"key":"3731_CR119","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24\u201335. https:\/\/doi.org\/10.1056\/NEJMoa0912217","journal-title":"N Engl J Med"},{"key":"3731_CR120","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","volume":"17","author":"B O'Sullivan","year":"2016","unstructured":"O\u2019Sullivan B, Huang SH, Su J et al (2016) Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 17:440\u2013451. https:\/\/doi.org\/10.1016\/S1470-2045(15)00560-4","journal-title":"Lancet Oncol"},{"key":"3731_CR121","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1007\/s12105-012-0371-6","volume":"6 Suppl 1","author":"WH Westra","year":"2012","unstructured":"Westra WH (2012) The morphologic profile of HPV-related head and neck squamous carcinoma: implications for diagnosis, prognosis, and clinical management. Head Neck Pathol 6 Suppl 1:S48-54. https:\/\/doi.org\/10.1007\/s12105-012-0371-6","journal-title":"Head Neck Pathol"},{"key":"3731_CR122","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","volume":"142","author":"JS Lewis Jr","year":"2018","unstructured":"Lewis JS Jr, Beadle B, Bishop JA et al (2018) Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists. Arch Pathol Lab Med 142:559\u2013597. https:\/\/doi.org\/10.5858\/arpa.2017-0286-CP","journal-title":"Arch Pathol Lab Med"},{"key":"3731_CR123","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1016\/S2352-3026(15)00002-2","volume":"2","author":"SJ Kim","year":"2015","unstructured":"Kim SJ, Choi JY, Hyun SH et al (2015) Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer\/T-cell lymphoma, nasal type: a multicentre, retrospective analysis. Lancet Haematol 2:e66-74. https:\/\/doi.org\/10.1016\/S2352-3026(15)00002-2","journal-title":"Lancet Haematol"},{"key":"3731_CR124","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.ejca.2014.06.006","volume":"50","author":"K Hussein","year":"2014","unstructured":"Hussein K, Rath B, Ludewig B et al (2014) Clinico-pathological characteristics of different types of immunodeficiency-associated smooth muscle tumours. Eur J Cancer 50:2417\u20132424. https:\/\/doi.org\/10.1016\/j.ejca.2014.06.006","journal-title":"Eur J Cancer"},{"key":"3731_CR125","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","volume":"34","author":"SD Dojcinov","year":"2010","unstructured":"Dojcinov SD, Venkataraman G, Raffeld M et al (2010) EBV positive mucocutaneous ulcer\u2013a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol 34:405\u2013417. https:\/\/doi.org\/10.1097\/PAS.0b013e3181cf8622","journal-title":"Am J Surg Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03731-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-023-03731-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-023-03731-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T12:06:07Z","timestamp":1710763567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-023-03731-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,13]]},"references-count":125,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["3731"],"URL":"https:\/\/doi.org\/10.1007\/s00428-023-03731-2","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,13]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"No patient consent was required for this review article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}